Arena reduces workforce by 25 percent and update on lorcaserin Arena Pharmaceuticals.

Related StoriesPatrolling monocytes may play anti-cancer role in the lungUCSD researchers develop new computational technique to discover tumor-shrinking moleculesRNA profiles of tumor-educated platelets may diagnose cancer tumor, recognize potential therapeutic approachesAs announced previously, nearly all activities relate with the three nonclinical problems outlined in the CRL. The first issue relates to the diagnostic uncertainty in the classification of mammary masses in female rats. Within addressing this presssing issue, Arena provides convened five independent pathologists to re-adjudicate the feminine rat mammary tumor diagnoses from the rat carcinogenicity study. The FDA has examined and agreed to Arena’s protocol, and this ongoing function is ongoing. The second issue pertains to demonstrating a system for mammary adenocarcinoma in female rats that is reasonably irrelevant to human risk.Officials at the California Division of Managed Health Care said they are looking into whether consumers were misled by inaccurate service provider lists and the difficulty some patients remain having at locating a physician in narrower systems statewide . The CT Mirror: Obamacare Glitch RESULTING IN Canceled Policies, Some Say Connecticut Republican leaders this week announced there's a new issue with Obamacare: Constituents calling to state their insurance policies have been canceled because the subsidies that help lower price their premiums hadn't been paid. Like various other controversies linked to the health law, this one fell into something of a gray area. Its scope was unclear: Were these isolated cases, or symptoms of a widespread issue? In an election year, just how much was this concern charged with politics? GOP leaders have already been critical of the state's medical health insurance Obamacare and exchange, and the way they described the problem wasn't fully accurate.